| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | MAM | 3.62e-06 | 17 | 120 | 4 | SM00137 | |
| Domain | MAM | 4.63e-06 | 18 | 120 | 4 | PF00629 | |
| Domain | MAM_dom | 4.63e-06 | 18 | 120 | 4 | IPR000998 | |
| Domain | MAM_2 | 4.63e-06 | 18 | 120 | 4 | PS50060 | |
| Domain | ACTININ_2 | 1.31e-05 | 23 | 120 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.31e-05 | 23 | 120 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.31e-05 | 23 | 120 | 4 | IPR001589 | |
| Domain | TILa_dom | 1.22e-04 | 3 | 120 | 2 | IPR025615 | |
| Domain | TILa | 1.22e-04 | 3 | 120 | 2 | PF12714 | |
| Domain | MAM_1 | 1.36e-04 | 16 | 120 | 3 | PS00740 | |
| Domain | Spectrin_bsu | 2.44e-04 | 4 | 120 | 2 | IPR016343 | |
| Domain | Spectrin | 4.17e-04 | 23 | 120 | 3 | PF00435 | |
| Domain | ConA-like_dom | 5.37e-04 | 219 | 120 | 7 | IPR013320 | |
| Domain | CH | 8.11e-04 | 65 | 120 | 4 | SM00033 | |
| Domain | EGF | 8.15e-04 | 235 | 120 | 7 | SM00181 | |
| Domain | Spectrin_repeat | 8.37e-04 | 29 | 120 | 3 | IPR002017 | |
| Domain | LA | 8.42e-04 | 7 | 120 | 2 | SM00715 | |
| Domain | HTH_LA | 8.42e-04 | 7 | 120 | 2 | PS50961 | |
| Domain | La | 8.42e-04 | 7 | 120 | 2 | PF05383 | |
| Domain | Lupus_La_RNA-bd | 8.42e-04 | 7 | 120 | 2 | IPR006630 | |
| Domain | Arm | 1.02e-03 | 31 | 120 | 3 | PF00514 | |
| Domain | CH | 1.07e-03 | 70 | 120 | 4 | PF00307 | |
| Domain | SPEC | 1.12e-03 | 32 | 120 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.12e-03 | 32 | 120 | 3 | IPR018159 | |
| Domain | - | 1.13e-03 | 71 | 120 | 4 | 1.10.418.10 | |
| Domain | EGF-like_dom | 1.14e-03 | 249 | 120 | 7 | IPR000742 | |
| Domain | FN3 | 1.25e-03 | 185 | 120 | 6 | SM00060 | |
| Domain | CH | 1.25e-03 | 73 | 120 | 4 | PS50021 | |
| Domain | CH-domain | 1.39e-03 | 75 | 120 | 4 | IPR001715 | |
| Domain | FN3 | 1.81e-03 | 199 | 120 | 6 | PS50853 | |
| Domain | FN3_dom | 2.32e-03 | 209 | 120 | 6 | IPR003961 | |
| Domain | C8 | 2.59e-03 | 12 | 120 | 2 | PF08742 | |
| Domain | TIL | 2.59e-03 | 12 | 120 | 2 | PF01826 | |
| Domain | Unchr_dom_Cys-rich | 3.05e-03 | 13 | 120 | 2 | IPR014853 | |
| Domain | C8 | 3.05e-03 | 13 | 120 | 2 | SM00832 | |
| Domain | Armadillo | 3.41e-03 | 47 | 120 | 3 | IPR000225 | |
| Domain | FN_type2_col-bd | 3.54e-03 | 14 | 120 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.54e-03 | 14 | 120 | 2 | PS51092 | |
| Domain | Dynein_HC_stalk | 3.54e-03 | 14 | 120 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.54e-03 | 14 | 120 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.54e-03 | 14 | 120 | 2 | PF08393 | |
| Domain | TIL_dom | 3.54e-03 | 14 | 120 | 2 | IPR002919 | |
| Domain | FN2_1 | 3.54e-03 | 14 | 120 | 2 | PS00023 | |
| Domain | MT | 3.54e-03 | 14 | 120 | 2 | PF12777 | |
| Domain | fn2 | 3.54e-03 | 14 | 120 | 2 | PF00040 | |
| Domain | FN2 | 3.54e-03 | 14 | 120 | 2 | SM00059 | |
| Domain | CUB | 3.84e-03 | 49 | 120 | 3 | PF00431 | |
| Domain | fn3 | 3.95e-03 | 162 | 120 | 5 | PF00041 | |
| Domain | CUB | 4.07e-03 | 50 | 120 | 3 | SM00042 | |
| Domain | DHC_fam | 4.07e-03 | 15 | 120 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.07e-03 | 15 | 120 | 2 | PF03028 | |
| Domain | Pept_M10A_Zn_BS | 4.07e-03 | 15 | 120 | 2 | IPR021158 | |
| Domain | Dynein_heavy_dom | 4.07e-03 | 15 | 120 | 2 | IPR004273 | |
| Domain | EGF_3 | 4.13e-03 | 235 | 120 | 6 | PS50026 | |
| Domain | - | 4.55e-03 | 52 | 120 | 3 | 2.60.120.290 | |
| Domain | VWF_type-D | 4.63e-03 | 16 | 120 | 2 | IPR001846 | |
| Domain | VWFD | 4.63e-03 | 16 | 120 | 2 | PS51233 | |
| Domain | VWD | 4.63e-03 | 16 | 120 | 2 | SM00216 | |
| Domain | VWD | 4.63e-03 | 16 | 120 | 2 | PF00094 | |
| Domain | CUB | 4.80e-03 | 53 | 120 | 3 | PS01180 | |
| Domain | Hemopexin_CS | 5.23e-03 | 17 | 120 | 2 | IPR018486 | |
| Domain | LH2 | 5.86e-03 | 18 | 120 | 2 | SM00308 | |
| Domain | Pept_M10A_stromelysin-type | 5.86e-03 | 18 | 120 | 2 | IPR016293 | |
| Domain | CUB_dom | 5.88e-03 | 57 | 120 | 3 | IPR000859 | |
| Domain | EGF_1 | 6.12e-03 | 255 | 120 | 6 | PS00022 | |
| Domain | ARM-type_fold | 6.32e-03 | 339 | 120 | 7 | IPR016024 | |
| Pubmed | Ott, a mouse X-linked multigene family expressed specifically during meiosis. | 2.45e-06 | 8 | 124 | 3 | 8842733 | |
| Pubmed | DLG5 WAPL FNDC3A SYNPO ADNP TUBGCP6 TRANK1 PLCH2 TMX4 EIF2AK4 MED13 | 3.27e-06 | 529 | 124 | 11 | 14621295 | |
| Pubmed | SPTBN1 APC SPOCK2 SYNPO CUBN DNAJC6 PLA2R1 SERPINB6 ATP8A1 CDC123 ANKEF1 BUB1 LTF CSMD1 PLS3 MED13 MYBPC1 | 3.61e-06 | 1293 | 124 | 17 | 15342556 | |
| Pubmed | 7.40e-06 | 35 | 124 | 4 | 11013070 | ||
| Pubmed | SYNPO2 RPS6KA5 SYNE1 SPTBN1 APC SYNPO POM121C FAM13B POM121 MPHOSPH9 | 1.02e-05 | 486 | 124 | 10 | 20936779 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29164307 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24412394 | ||
| Pubmed | Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis. | 1.26e-05 | 2 | 124 | 2 | 28825595 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 26073472 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 18029446 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11461154 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 24387768 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 17671179 | ||
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 1.26e-05 | 2 | 124 | 2 | 24408017 | |
| Pubmed | STAT2 Controls Colorectal Tumorigenesis and Resistance to Anti-Cancer Drugs. | 1.26e-05 | 2 | 124 | 2 | 38001683 | |
| Pubmed | Interaction of the transcriptional activator Stat-2 with the type I interferon receptor. | 1.26e-05 | 2 | 124 | 2 | 7559568 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9677371 | ||
| Pubmed | CD147 is a Novel Interaction Partner of Integrin αMβ2 Mediating Leukocyte and Platelet Adhesion. | 1.26e-05 | 2 | 124 | 2 | 32252487 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 12357430 | ||
| Pubmed | Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours. | 1.26e-05 | 2 | 124 | 2 | 20208994 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 36436563 | ||
| Pubmed | The influence of the peptide NAP on Mac-1-deficient mice following closed head injury. | 1.26e-05 | 2 | 124 | 2 | 16042992 | |
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 1.26e-05 | 2 | 124 | 2 | 27890662 | |
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 1.26e-05 | 2 | 124 | 2 | 21439553 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23055343 | ||
| Pubmed | A joint study of whole exome sequencing and structural MRI analysis in major depressive disorder. | 1.26e-05 | 2 | 124 | 2 | 30722798 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 32219372 | ||
| Pubmed | Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis. | 1.26e-05 | 2 | 124 | 2 | 18391979 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7782276 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 29746837 | ||
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 16452088 | ||
| Pubmed | DLG5 PDE3B SYNE1 SPTBN1 FNDC3A AIP DNAJC6 THOC5 LARP7 TUBGCP6 CDC123 BSG ZNF644 TMX4 PLS3 SNX2 FTSJ3 | 2.22e-05 | 1487 | 124 | 17 | 33957083 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.47e-05 | 18 | 124 | 3 | 12119179 | |
| Pubmed | 3.65e-05 | 347 | 124 | 8 | 17114649 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11294830 | ||
| Pubmed | Affinity of Stat2 for the subunits of the interferon alpha receptor. | 3.77e-05 | 3 | 124 | 2 | 12220192 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 12906867 | ||
| Pubmed | Methyltransferase SETD2-Mediated Methylation of STAT1 Is Critical for Interferon Antiviral Activity. | 3.77e-05 | 3 | 124 | 2 | 28753426 | |
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 3.77e-05 | 3 | 124 | 2 | 30802453 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 10958656 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 26456319 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 35507432 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25024400 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 20696710 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15723812 | ||
| Pubmed | Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. | 3.77e-05 | 3 | 124 | 2 | 17227893 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 24747657 | ||
| Pubmed | SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury. | 3.77e-05 | 3 | 124 | 2 | 29377313 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11163195 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 11786546 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 3.77e-05 | 3 | 124 | 2 | 32425157 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 31730616 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 19561067 | ||
| Pubmed | Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. | 3.77e-05 | 3 | 124 | 2 | 35708626 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 28026816 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 32748631 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 27034204 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 21079361 | ||
| Pubmed | Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. | 3.77e-05 | 3 | 124 | 2 | 26019270 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 25514805 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 8479293 | ||
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 3.77e-05 | 3 | 124 | 2 | 1467942 | |
| Pubmed | A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. | 3.77e-05 | 3 | 124 | 2 | 26901816 | |
| Pubmed | Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. | 4.11e-05 | 19 | 124 | 3 | 14671302 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 4.22e-05 | 697 | 124 | 11 | 28298427 | |
| Pubmed | 4.63e-05 | 263 | 124 | 7 | 34702444 | ||
| Pubmed | 4.82e-05 | 20 | 124 | 3 | 33888907 | ||
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 4.82e-05 | 20 | 124 | 3 | 35224516 | |
| Pubmed | RELN WAPL TNPO2 SYNE1 SPTB SPTBN1 APC SPOCK2 SYNPO AIP RYR3 PTPRK NGEF CTNND2 MED13 | 5.54e-05 | 1285 | 124 | 15 | 35914814 | |
| Pubmed | WAPL APC FNDC3A AIP JMJD1C STAT2 SETD2 AUNIP TPX2 MPHOSPH9 ITPRIPL1 | 6.62e-05 | 733 | 124 | 11 | 34672954 | |
| Pubmed | 6.74e-05 | 118 | 124 | 5 | 30979931 | ||
| Pubmed | Stat2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsis. | 7.53e-05 | 4 | 124 | 2 | 23653476 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 30814285 | ||
| Pubmed | TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction. | 7.53e-05 | 4 | 124 | 2 | 33811647 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9660858 | ||
| Pubmed | Zika virus spreads through infection of lymph node-resident macrophages. | 7.53e-05 | 4 | 124 | 2 | 36795561 | |
| Pubmed | IDO1+ Paneth cells promote immune escape of colorectal cancer. | 7.53e-05 | 4 | 124 | 2 | 32444775 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 15964802 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21379341 | ||
| Pubmed | A role for the Adenomatous Polyposis Coli protein in chromosome segregation. | 7.53e-05 | 4 | 124 | 2 | 11283619 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 7.53e-05 | 4 | 124 | 2 | 17900573 | |
| Pubmed | IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. | 7.53e-05 | 4 | 124 | 2 | 10490982 | |
| Pubmed | Differential expression of MAM-subfamily protein tyrosine phosphatases during mouse development. | 7.53e-05 | 4 | 124 | 2 | 9510027 | |
| Pubmed | Promoter hypermethylation in circulating blood cells identifies prostate cancer progression. | 7.53e-05 | 4 | 124 | 2 | 17960617 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 15356134 | ||
| Pubmed | Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. | 7.53e-05 | 4 | 124 | 2 | 18058812 | |
| Pubmed | DNA methylation markers and early recurrence in stage I lung cancer. | 7.53e-05 | 4 | 124 | 2 | 18337602 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 7.53e-05 | 4 | 124 | 2 | 3862089 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 21412925 | ||
| Pubmed | ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes. | 7.53e-05 | 4 | 124 | 2 | 30517866 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 11673475 | ||
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 31505764 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 7.53e-05 | 4 | 124 | 2 | 12820899 | |
| Pubmed | Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. | 7.53e-05 | 4 | 124 | 2 | 17475855 | |
| Pubmed | 7.53e-05 | 4 | 124 | 2 | 9121453 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 20455995 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 26612263 | ||
| Pubmed | 1.25e-04 | 5 | 124 | 2 | 19962666 | ||
| Pubmed | Prognostic DNA methylation marker in serum of cancer patients. | 1.25e-04 | 5 | 124 | 2 | 15251938 | |
| Interaction | LOC102724334 interactions | 1.58e-06 | 134 | 122 | 8 | int:LOC102724334 | |
| Cytoband | 1p22.2 | 5.85e-05 | 28 | 123 | 3 | 1p22.2 | |
| Cytoband | 1q32 | 3.16e-04 | 49 | 123 | 3 | 1q32 | |
| GeneFamily | EF-hand domain containing|Spectrins | 3.90e-04 | 7 | 79 | 2 | 1113 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 3.90e-04 | 7 | 79 | 2 | 625 | |
| GeneFamily | Fibronectin type III domain containing | 6.78e-04 | 160 | 79 | 5 | 555 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 6.32e-07 | 208 | 123 | 9 | MM581 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 6.04e-06 | 206 | 123 | 8 | M2817 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | WAPL RPS6KA5 SYNE1 RSF1 SPOCK2 TAB2 AIP FAM13B JMJD1C SIRPG CREBRF SETD2 TRANK1 ATP8A1 ZNF644 ELK4 TRAF3IP3 FMNL1 MED13 TBCC | 2.04e-05 | 1492 | 123 | 20 | M40023 |
| Coexpression | GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP | 4.28e-05 | 198 | 123 | 7 | M5586 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 4.42e-05 | 199 | 123 | 7 | M9414 | |
| Coexpression | GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP | 4.56e-05 | 200 | 123 | 7 | M8320 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-08 | 169 | 124 | 8 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.15e-08 | 185 | 124 | 8 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 5.83e-08 | 188 | 124 | 8 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.69e-08 | 198 | 124 | 8 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.46e-07 | 172 | 124 | 7 | 1215f61f115b042f84721b64c2ed1f48081535f1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 178 | 124 | 7 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-07 | 178 | 124 | 7 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 181 | 124 | 7 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.69e-07 | 181 | 124 | 7 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.22e-06 | 194 | 124 | 7 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.27e-06 | 195 | 124 | 7 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 1.40e-06 | 198 | 124 | 7 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.40e-06 | 198 | 124 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.50e-06 | 200 | 124 | 7 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 93 | 124 | 5 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 93 | 124 | 5 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 93 | 124 | 5 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.43e-06 | 167 | 124 | 6 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.51e-06 | 171 | 124 | 6 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.00e-05 | 176 | 124 | 6 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.07e-05 | 178 | 124 | 6 | a34bb693b72684cbd97ac9efff77d2d14e41be75 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 179 | 124 | 6 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 179 | 124 | 6 | 9863ab3ceb160a4b1d9790033a4ac48845863d65 | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 179 | 124 | 6 | dfe110add7228cd834b35916cbcc849769a01bb9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 183 | 124 | 6 | a97f052950429245c3231464271e1ba539863bba | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.25e-05 | 183 | 124 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 184 | 124 | 6 | 1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-05 | 184 | 124 | 6 | e6bf826be31e1723e24c366fc5a1cee9b15589bc | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-05 | 184 | 124 | 6 | 8578c50eaa8ce1cefc0228185c66c8e25f4bfc32 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 184 | 124 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 184 | 124 | 6 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 190 | 124 | 6 | d83fdc352ebb0c2f2a7c2138bf6e3b7a8ce83a6a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.69e-05 | 193 | 124 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | remission|World / disease stage, cell group and cell class | 1.69e-05 | 193 | 124 | 6 | 86cfd0c230ba96a43d343216935952fff6a5254e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 193 | 124 | 6 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-05 | 193 | 124 | 6 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.69e-05 | 193 | 124 | 6 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-05 | 193 | 124 | 6 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.74e-05 | 194 | 124 | 6 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.74e-05 | 194 | 124 | 6 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | PSB-critical-LOC-Lymphoid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.85e-05 | 196 | 124 | 6 | 7b5c2a4cdea9a944f83bfc2c493d3076c3daaeaa | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 196 | 124 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 197 | 124 | 6 | adc7bf2120fad4aea58123d882a8cf18ed4174d0 | |
| ToppCell | Severe-Lymphoid-T-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 1.90e-05 | 197 | 124 | 6 | 00d884ec591f63a345d7fd0a6b368f9da4b4c6ce | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-05 | 197 | 124 | 6 | e133bd09efc6d7f539fc1a1ac7a945f07103d6e6 | |
| ToppCell | Severe_COVID-19-T/NK-CD8+_T|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.95e-05 | 198 | 124 | 6 | 584f0dc6f22bb13956a5f6950698599e382907e9 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.95e-05 | 198 | 124 | 6 | 08f9f05abad4e4078362ea8537c616084cb5d70a | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 2eb80255bacddbf778b1c9eec09f74b4cdb09b36 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | ec99da4e269c4cd982a395cdac0e4487ab14ec39 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.95e-05 | 198 | 124 | 6 | 06fdf8554148d11c0a946a7fd200edd9fa7e1965 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 199 | 124 | 6 | 9936196214a12502ebfaf152d39d40a2ed83c72d | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 2.01e-05 | 199 | 124 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Severe-Lymphoid|Severe / Condition, Lineage, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | 928e346b0f31d991ebab12fefb4eb9f4249e601d | |
| ToppCell | Severe-Lymphoid-T|Severe / Condition, Lineage, Cell class and cell subclass | 2.01e-05 | 199 | 124 | 6 | ad2be3739721b7bfc2bd50eafd01d4325b01016e | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_T_naive|Control / Disease, condition lineage and cell class | 2.07e-05 | 200 | 124 | 6 | 906de95adc9716982ab32f216dddeb52639bad06 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-05 | 119 | 124 | 5 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.19e-05 | 130 | 124 | 5 | 6c6a8b77af08b30b424d4f5def37315d3c6e28b2 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesenchymal_fibroblast-mesenchymal_B|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.19e-05 | 130 | 124 | 5 | 0706092f6b466585b3b4808b3b982a122d66cfcf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.55e-05 | 146 | 124 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Control-Lymphocytic_NKT-iNKT/MAIT-T-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-05 | 148 | 124 | 5 | 003e10bf477984248211b99d75daa8f7dcdb12c8 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-05 | 148 | 124 | 5 | 5983c4546f527a0b599cfcbd8a6cb937a1d6f895 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.92e-05 | 148 | 124 | 5 | 6ffa212f0cc44c40d2143816dc6cfd82fbf09a33 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.11e-05 | 149 | 124 | 5 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 6.71e-05 | 152 | 124 | 5 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 154 | 124 | 5 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.14e-05 | 154 | 124 | 5 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.36e-05 | 155 | 124 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 8.30e-05 | 159 | 124 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.07e-05 | 162 | 124 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 167 | 124 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-04 | 167 | 124 | 5 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 169 | 124 | 5 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 169 | 124 | 5 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 169 | 124 | 5 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 170 | 124 | 5 | dbd6c9c7be824a1ff1b31af791064127cafbd194 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 170 | 124 | 5 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | Severe-Lymphoid-T-|Severe / Condition, Lineage, Cell class and cell subclass | 1.14e-04 | 170 | 124 | 5 | 5788e1158fde036937d41708e9db3222ca351eb1 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 124 | 5 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.20e-04 | 172 | 124 | 5 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 172 | 124 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.23e-04 | 173 | 124 | 5 | 2e35bf2b5534a289d93a09faae660f665c131062 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 173 | 124 | 5 | 506efcaa5afd6ed5e565c4c4def6a4505fea97c5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 173 | 124 | 5 | 9f892d756d05e573af018db64edb130ff187ad47 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 173 | 124 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 174 | 124 | 5 | ecdff386d7f0bc57c170a2c1f4deae5ba7e431b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 174 | 124 | 5 | 47e308a777c927ae69ed344cb3dd8561bf2c48a5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 174 | 124 | 5 | a92c745d20633909db0f08effa13fc738fda79a6 | |
| Computational | Metal / Ca ion binding. | 9.04e-05 | 133 | 86 | 7 | MODULE_324 | |
| Disease | Gastrointestinal Hemorrhage | 5.55e-06 | 9 | 121 | 3 | C0017181 | |
| Disease | Colorectal Carcinoma | CHL1 SYNE1 PPM1E APC CUBN CINP ITPRID1 ZNF540 BUB1 TPX2 TRAF3IP3 CTNND2 | 3.30e-05 | 702 | 121 | 12 | C0009402 |
| Disease | secretory phospholipase A2 receptor measurement | 4.99e-05 | 3 | 121 | 2 | EFO_0802043 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 9.95e-05 | 4 | 121 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | Hematochezia | 9.95e-05 | 4 | 121 | 2 | C0018932 | |
| Disease | spermidine measurement | 1.65e-04 | 5 | 121 | 2 | EFO_0021802 | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.89e-04 | 69 | 121 | 4 | DOID:4450 (is_implicated_in) | |
| Disease | alcohol consumption measurement | TMEM182 DLG5 RELN WAPL ACACB UNCX RPS6KA5 SPTBN1 LARP7 CNTNAP5 PTPRK CTNND2 CSMD1 HTT | 5.80e-04 | 1242 | 121 | 14 | EFO_0007878 |
| Disease | alkaline phosphatase measurement | DLG5 ACACB RPS6KA5 SPTBN1 LARP1B JMJD1C TRANK1 POM121 ASL HFM1 LTF KIF17 | 9.68e-04 | 1015 | 121 | 12 | EFO_0004533 |
| Disease | mean platelet volume | ZAN SPTBN1 RSF1 JMJD1C SIRPG SETD2 TRANK1 LY75 PLS3 ALOX12 SNX2 HTT | 1.01e-03 | 1020 | 121 | 12 | EFO_0004584 |
| Disease | cannabis dependence measurement | 1.02e-03 | 48 | 121 | 3 | EFO_0008457 | |
| Disease | Schizophrenia | CHL1 RELN APC CSMD2 ADNP ITGAM MMP3 CTNND2 CSMD1 KIF17 ALOX12 | 1.04e-03 | 883 | 121 | 11 | C0036341 |
| Disease | endometrial carcinoma (is_implicated_in) | 1.07e-03 | 12 | 121 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | bone fracture | 1.19e-03 | 112 | 121 | 4 | EFO_0003931 | |
| Disease | matrix metalloproteinase measurement | 1.26e-03 | 13 | 121 | 2 | EFO_0004744 | |
| Disease | facial morphology | 1.51e-03 | 55 | 121 | 3 | EFO_0004743 | |
| Disease | microglial activation measurement | 1.85e-03 | 59 | 121 | 3 | EFO_0010940 | |
| Disease | platelet crit | ANKRD31 CUBN FAM13B JMJD1C SIRPG PLA2R1 SERPINB6 HFM1 MPHOSPH9 LY75 SNX2 | 1.89e-03 | 952 | 121 | 11 | EFO_0007985 |
| Disease | N-acetyl-beta-alanine measurement | 1.93e-03 | 16 | 121 | 2 | EFO_0021430 | |
| Disease | Huntington Disease | 2.18e-03 | 17 | 121 | 2 | C0020179 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.18e-03 | 17 | 121 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 2.18e-03 | 17 | 121 | 2 | C0015923 | |
| Disease | Intellectual Disability | 2.51e-03 | 447 | 121 | 7 | C3714756 | |
| Disease | hearing loss | 2.66e-03 | 67 | 121 | 3 | EFO_0004238 | |
| Disease | sporadic amyotrophic lateral sclerosis | 2.69e-03 | 140 | 121 | 4 | EFO_0001357 | |
| Disease | Osteoarthritis of hip | 3.02e-03 | 20 | 121 | 2 | C0029410 | |
| Disease | Bipolar Disorder | 3.59e-03 | 477 | 121 | 7 | C0005586 | |
| Disease | blood pressure | 3.65e-03 | 22 | 121 | 2 | EFO_0004325 | |
| Disease | transitional cell carcinoma (is_implicated_in) | 3.65e-03 | 22 | 121 | 2 | DOID:2671 (is_implicated_in) | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 3.65e-03 | 22 | 121 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | platelet component distribution width | 3.98e-03 | 755 | 121 | 9 | EFO_0007984 | |
| Disease | urate measurement, bone density | 4.06e-03 | 619 | 121 | 8 | EFO_0003923, EFO_0004531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKDQSQWKNASENDE | 1041 | Q9H2P0 | |
| DKDEWQSLDQNEDAF | 486 | O43683 | |
| ADIFVSKFENDNWGL | 3421 | Q96PZ7 | |
| NWDSLEVFDGADNTV | 1846 | Q7Z408 | |
| EWDADEQAFNTTVKQ | 1591 | Q9P2K8 | |
| DVLDNEGALTSNWEQ | 76 | Q8IUR6 | |
| QRNTDEDKWGDACDN | 336 | P49747 | |
| AQENFSEDGDAILWE | 691 | Q9UK96 | |
| EKGANVNATDNFLWT | 546 | Q9NU02 | |
| EGELAQWEDFSNSNS | 2711 | Q96M86 | |
| QFQWQSQDGQKDIED | 101 | Q9UQB3 | |
| SQNDWKLDVATDNFF | 31 | Q96GG9 | |
| NDDINDNDWSYGSEK | 136 | Q14CW9 | |
| EWQNSQFGDEKTFSD | 446 | Q9Y2Q0 | |
| AAVWNAQEAQADFAK | 276 | O00170 | |
| VLKENDSGEVNWDAF | 286 | Q9NS23 | |
| DRQSFENLGNWQKEF | 91 | Q9NP90 | |
| LETESFQNNDIDTGW | 741 | O00763 | |
| WENSFLSFVKENSDN | 886 | Q8N7Z5 | |
| DEDENWTKDGAGFNL | 196 | Q9H306 | |
| GGQDQFNWEDVKTDK | 11 | Q9BU76 | |
| DSDKWQSGLSINNVF | 96 | Q6PIW4 | |
| DAEAWFNEKSASLQQ | 276 | Q7Z3Y7 | |
| NWGDNDSIFQDVIET | 1051 | O00533 | |
| DSKQESIQQWLDSGF | 56 | Q6ZRS4 | |
| TQEWLEAINSDFEGN | 146 | Q5JYT7 | |
| AEEWAQGTFKLNSND | 71 | P04424 | |
| SNANVKEFWDGFEEV | 2231 | Q15652 | |
| FKSWQEDSESGEAQL | 486 | Q9NYF5 | |
| INGDAHFDDDEQWTK | 191 | P08254 | |
| DEEEQALWFNGTTDN | 291 | Q6H9L7 | |
| DGNNTSFWSEEIKFD | 311 | P17181 | |
| LENSGWQKINNFSAD | 281 | P13797 | |
| NAKANDVNSNGIEWS | 906 | Q13370 | |
| VGQSDDESINFDAWL | 251 | P35663 | |
| LFNEDWDSELKADQG | 111 | Q9NQ92 | |
| SWSGQNIFENIKDSD | 801 | Q8TDM6 | |
| FKNWGTQTEKEDTSN | 756 | Q99550 | |
| DTDGFWKTVDCNDNQ | 1201 | O60449 | |
| ADIAKQVDFWFGDAN | 36 | Q4G0J3 | |
| QWDTAGFENEDQKLK | 361 | Q1ED39 | |
| KGDNQNDSWIFALAV | 106 | P32455 | |
| SVDQWEDEGFQSASN | 251 | Q96RT7 | |
| FSFEGEAWKNVSQEA | 646 | O75582 | |
| EDFDQIFWGQKSALA | 201 | P18054 | |
| RYQNNESEDSEEWKG | 21 | Q13316 | |
| FQDKFDGSIDLQANW | 1606 | P78509 | |
| LQWFNQALEDKSDAA | 521 | A8CG34 | |
| NVSEESDWTENSFQG | 496 | Q8WY54 | |
| NVNFELGNEVWDDFD | 1261 | A2PYH4 | |
| AYQEKEEVGSCWNDS | 496 | Q5K4E3 | |
| WFNQALEDKSDAASN | 546 | Q96HA1 | |
| AEQRQKAENFWTGDT | 66 | Q6GPH6 | |
| KAENFWTGDTSSDQL | 71 | Q6GPH6 | |
| NFETGICNWEQDAKD | 866 | Q5VYJ5 | |
| NSSGCEKDFVEIWDN | 2386 | O60494 | |
| QNSFVKVWAGTEEVD | 2861 | O60494 | |
| NLSSDDFNDKWIASN | 901 | Q9P2D7 | |
| AEQENDTSGWFDVLQ | 1381 | P42858 | |
| WEELISENNLNGDFS | 261 | O75794 | |
| WSKGNFSNEELSDLE | 71 | P29017 | |
| WTSNDGQFKLLQAEE | 26 | P28324 | |
| DGDQTNDWHDSQEKP | 5376 | Q9Y6R7 | |
| GEWNKESSNNEQDNS | 756 | Q8IW35 | |
| DNGSKIQNFVLEWDE | 396 | Q9Y2H6 | |
| VQQNGASDFSWAKEA | 346 | Q86WU2 | |
| ELNDAWSEFENQGQK | 896 | O75061 | |
| QKTEFKVDSDDQWGE | 186 | P35613 | |
| QWKKEAAAQEAGADT | 1006 | O95466 | |
| GSNKEWQDVEDFARA | 226 | O60381 | |
| YIEEQDDQDGSSWKC | 176 | Q96T23 | |
| GRADVQDWAKEQTFT | 481 | Q9Y2C5 | |
| KDSWSQLFTEDSQGQ | 281 | Q9H7T9 | |
| NCDADKDEWTNDTGF | 736 | Q8WYK1 | |
| QIGRKNTFTDWSDND | 421 | Q659C4 | |
| EGQSASWDVAKKDQN | 896 | Q15262 | |
| SEGDDFNWEQVNTLT | 41 | P28827 | |
| LVAALQNSDEDSGDW | 781 | Q9P2E2 | |
| QNSDEDSGDWVLLNV | 786 | Q9P2E2 | |
| ESDAWFEEKQQQFEN | 301 | O60749 | |
| DQNWQEAALGSDDSK | 41 | P52630 | |
| QNTDGNNNEAWAKDL | 571 | P02788 | |
| LEDAVDEWTGFNNKV | 5206 | Q8NF91 | |
| KTQDTEDDEGAQWNC | 656 | Q9NYJ8 | |
| DDRASQDWDVVKAGQ | 101 | Q8N3V7 | |
| WNEVDKQAIDESTNG | 1841 | Q9NTG1 | |
| SASDQWNTDNEPAKV | 16 | Q8N5V2 | |
| LQEEQANLWFSKGSF | 521 | Q8IY81 | |
| GNWDEQFDKENTEER | 171 | P35237 | |
| FWDDGETKDTIQNGN | 831 | P14410 | |
| VAEWFSQAADGNNEA | 1431 | Q9UHV7 | |
| EEFNATLKGNLSFDW | 1041 | P11215 | |
| VEGQGWQAFKNDATE | 21 | Q9BQB4 | |
| KWFKNGNELSDFQTN | 181 | Q9P1W8 | |
| NAQFDGNNETIKWFD | 1316 | Q13018 | |
| SNSNQWSEKGDKDAE | 361 | Q8N1H7 | |
| EEAESQQQWDTSKGE | 2111 | Q01082 | |
| ENAEDKVNNSTGKWS | 6 | Q8NF67 | |
| SENFDWKAIQEGANS | 2096 | P25054 | |
| KWETLNDAGFTTANN | 36 | Q9BW66 | |
| IQASDSSWKGQLNED | 226 | Q9Y228 | |
| SCQQTDSEWEAFAKN | 66 | Q9H1E5 | |
| DSEWEAFAKNGEILQ | 71 | Q9H1E5 | |
| WDKNAPDEDSTNVAF | 306 | P47901 | |
| SIFRNEWQNKSEFEG | 116 | Q8NDQ6 | |
| SDVDDNTQVVNFDWD | 451 | Q9UMS6 | |
| KLQAQVQEFDENDGW | 746 | Q99973 | |
| VQEFDENDGWSLNTF | 751 | Q99973 | |
| ETEDVANLWNSFNDE | 4441 | Q15413 | |
| DQWLKQTFDEADKNG | 171 | O75038 | |
| GFKDQVGEDNWQQFS | 866 | O14787 | |
| WDVQTDSNPNQEKDS | 886 | Q8IZM8 | |
| TNDNEWGSTKTGEQD | 941 | Q7Z5K2 | |
| SGLDRSKNNWNDVDD | 306 | Q15814 | |
| FQFQGDADDLKAWLQ | 746 | P11277 | |
| WDQQDGSHFSDQSDK | 1341 | Q9BYW2 | |
| FRSENDTNWDPQKEF | 251 | Q9H582 | |
| FKDVSVDFTQEEWGQ | 76 | Q9UJL9 | |
| VEDNFSWDEKFKQNG | 26 | Q8NF99 | |
| GFQFQWKEDETNDHA | 96 | P17035 | |
| FSTSEQDKDNWNGQL | 416 | Q7Z2W7 | |
| WKGEKTNSNDDNIRA | 586 | Q13769 | |
| NRGKEGNDDQDDWST | 761 | O15050 | |
| DENQDRGNWSKKSDY | 31 | Q9UN76 | |
| FNGIVEENDSNIWKF | 61 | Q6ZP80 | |
| VQEALQWEAGEASSD | 536 | Q9BYX2 | |
| KSWEDNQQGDEALDT | 71 | Q92563 | |
| NFTGWQLEELEKAFN | 111 | A6NJT0 | |
| NTFGNSWEVKTEDAL | 2491 | Q9Y493 | |
| GDTQNIDSWFEEKAN | 26 | Q9ULW0 | |
| SEDDANVKWFKNGEE | 366 | Q00872 |